Condition

Breast Cancers

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19
Recruiting8
Common interventions23
Lead sponsors shown15
Advertisement

Clinical trials

19 shown
Partial Breast Re-irradiation for Breast CancerNCT06954623 · 2025-08-28
RECRUITING
Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast CancerNCT07095023 · 2025-08-15
RECRUITING
Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast CancerNCT06606730 · 2025-07-23
RECRUITING
Sustainable Implementation of the EXCEL Exercise Oncology Program Across CanadaNCT06960291 · 2025-03-11
RECRUITING
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer PatientsNCT06811870 · 2025-02-01
RECRUITING
Tirzepatide Weight Loss for MRD+ Early Breast CancerNCT06517212 · 2024-11-26
RECRUITING
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyNCT06805812 · 2023-05-01
RECRUITING
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene MutationNCT03667417 · 1999-10-15
RECRUITING
EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast CancersNCT07018505 · 2025-06-15
NOT_YET_RECRUITING
Prediction of ICG for Skin Necrosis in Mastectomy With Immediate ReconstructionNCT06956443 · 2025-06-01
NOT_YET_RECRUITING
Breast Cancer PET/CT Imaging With 68Ga-pAKTiNCT06943313 · 2025-04-21
ENROLLING_BY_INVITATION
A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer PatientsNCT06825949 · 2025-02-15
NOT_YET_RECRUITING
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer PatientsNCT06825975 · 2025-02-12
NOT_YET_RECRUITING
Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel AnalogsNCT06819501 · 2025-02-05
NOT_YET_RECRUITING
Study on Sleep, Lifestyle and Quality of Life in Women With Breast CancerNCT06662864 · 2023-06-01
COMPLETED
Examining the Effectiveness of Multidisciplinary Care Teams in Improving Outcomes for Breast Cancer PatientsNCT06856876 · 2021-05-01
COMPLETED
Dendritic Cell Vaccination for Patients with Solid TumorsNCT01291420 · 2010-05-03
COMPLETED
The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological CancersNCT00248911 · 2003-05-01
COMPLETED
Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer TherapiesNCT00721903 · 2000-03-01
COMPLETED

Common interventions

Trial status mix

RECRUITING8
COMPLETED5
NOT_YET_RECRUITING5
ENROLLING_BY_INVITATION1

Phase mix

NA9
PHASE23
PHASE12
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.